MR Imaging–Based Radiomic Signatures of Distinct Molecular Subgroups of Medulloblastoma

References

1. 1.↵
   2. Pollack IF,
   3. Jakacki RI

   . Childhood brain tumors: epidemiology, current management and future directions. Nat Rev Neurol 2011;7:495–506 doi:10.1038/nrneurol.2011.110 pmid:21788981

   CrossRefPubMed
2. 2.↵
   2. Kool M,
   3. Korshunov A,
   4. Remke M, et al

   . Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, group 3, and group 4 medulloblastomas. Acta Neuropathol 2012;123:473–84 doi:10.1007/s00401-012-0958-8 pmid:22358457

   CrossRefPubMedWeb of Science
3. 3.↵
   2. Northcott PA,
   3. Korshunov A,
   4. Witt H, et al

   . Medulloblastoma comprises four distinct molecular variants. J Clin Oncol 2011;29:1408–14 doi:10.1200/JCO.2009.27.4324 pmid:20823417

   Abstract/FREE Full Text
4. 4.↵
   2. Taylor MD,
   3. Northcott PA,
   4. Korshunov A, et al

   . Molecular subgroups of medulloblastoma: the current consensus. Acta Neuropathol 2012;123:465–72 doi:10.1007/s00401-011-0922-z pmid:22134537

   CrossRefPubMedWeb of Science
5. 5.↵
   2. Ramaswamy V,
   3. Remke M,
   4. Bouffet E, et al

   . Risk stratification of childhood medulloblastoma in the molecular era: the current consensus. Acta Neuropathol 2016;131:821–31 doi:10.1007/s00401-016-1569-6 pmid:27040285

   CrossRefPubMed
6. 6.↵
   2. Louis DN,
   3. Perry A,
   4. Reifenberger G, et al

   . The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol 2016;131:803–20 doi:10.1007/s00401-016-1545-1 pmid:27157931

   CrossRefPubMed
7. 7.↵
   2. Gajjar AJ,
   3. Robinson GW

   . Medulloblastoma-translating discoveries from the bench to the bedside. Nat Rev Clin Oncol 2014;11:714–22 doi:10.1038/nrclinonc.2014.181 pmid:25348790

   CrossRefPubMed
8. 8.↵
   2. Archer TC,
   3. Mahoney EL,
   4. Pomeroy SL

   . Medulloblastoma: molecular classification-based personal therapeutics. Neurotherapeutics 2017;14:265–73 doi:10.1007/s13311-017-0526-y pmid:28386677

   CrossRefPubMed
9. 9.↵
   2. Morrissy AS,
   3. Cavalli FM,
   4. Remke M, et al

   . Spatial heterogeneity in medulloblastoma. Nat Genet 2017;49:780–88 doi:10.1038/ng.3838 pmid:28394352

   CrossRefPubMed
10. 10.↵
    2. Zhou M,
    3. Scott J,
    4. Chaudhury B, et al

    . Radiomics in brain tumor: image assessment, quantitative feature descriptors, and machine-learning approaches. AJNR Am J Neuroradiol 2018;39:208–16 doi:10.3174/ajnr.A5391 pmid:28982791

    Abstract/FREE Full Text
11. 11.↵
    2. Gevaert O,
    3. Xu J,
    4. Hoang CD, et al

    . Non-small cell lung cancer: identifying prognostic imaging biomarkers by leveraging public gene expression microarray data–methods and preliminary results. Radiology 2012;264:387–96 doi:10.1148/radiol.12111607 pmid:22723499

    CrossRefPubMed
12. 12.↵
    2. Itakura H,
    3. Achrol AS,
    4. Mitchell LA, et al

    . Magnetic resonance image features identify glioblastoma phenotypic subtypes with distinct molecular pathway activities. Sci Transl Med 2015;7:303ra138 doi:10.1126/scitranslmed.aaa7582 pmid:26333934

    Abstract/FREE Full Text
13. 13.↵
    2. Gevaert O,
    3. Mitchell LA,
    4. Achrol AS, et al

    . Glioblastoma multiforme: exploratory radiogenomic analysis by using quantitative image features. Radiology 2014;273:168–74 doi:10.1148/radiol.14131731 pmid:24827998

    CrossRefPubMedWeb of Science
14. 14.↵
    2. Kickingereder P,
    3. Bonekamp D,
    4. Nowosielski M, et al

    . Radiogenomics of glioblastoma: machine learning-based classification of molecular characteristics by using multiparametric and multiregional MR imaging features. Radiology 2016;281:907–18 doi:10.1148/radiol.2016161382 pmid:27636026

    CrossRefPubMed
15. 15.↵
    2. Jamshidi N,
    3. Diehn M,
    4. Bredel M, et al

    . Illuminating radiogenomic characteristics of glioblastoma multiforme through integration of MR imaging, messenger RNA expression, and DNA copy number variation. Radiology 2014;270:1–2 doi:10.1148/radiol.13130078 pmid:24056404

    CrossRefPubMed
16. 16.↵
    2. Zhou M,
    3. Chaudhury B,
    4. Hall LO, et al

    . Identifying spatial imaging biomarkers of glioblastoma multiforme for survival group prediction. J Magn Reson Imaging 2017;46:115–23 doi:10.1002/jmri.25497 pmid:27678245

    CrossRefPubMed
17. 17.↵
    2. Banerjee S,
    3. Wang DS,
    4. Kim HJ, et al

    . A computed tomography radiogenomic biomarker predicts microvascular invasion and clinical outcomes in hepatocellular carcinoma. Hepatology 2015;62:792–800 doi:10.1002/hep.27877 pmid:25930992

    CrossRefPubMed
18. 18.↵
    2. Stoyanova R,
    3. Takhar M,
    4. Tschudi Y, et al

    . Prostate cancer radiomics and the promise of radiogenomics. Transl Cancer Res 2016;5:432–47 doi:10.21037/tcr.2016.06.20 pmid:29188191

    CrossRefPubMed
19. 19.↵
    2. Grimm LJ

    . Breast MRI radiogenomics: current status and research implications. J Magn Reson Imaging 2016;43:1269–78 doi:10.1002/jmri.25116 pmid:26663695

    CrossRefPubMed
20. 20.↵
    2. Gibson P,
    3. Tong Y,
    4. Robinson G, et al

    . Subtypes of medulloblastoma have distinct developmental origins. Nature 2010;468:1095–99 doi:10.1038/nature09587 pmid:21150899

    CrossRefPubMedWeb of Science
21. 21.↵
    2. Lastowska M,
    3. Jurkiewicz E,
    4. Trubicka J, et al

    . Contrast enhancement pattern predicts poor survival for patients with non-WNT/SHH medulloblastoma tumours. J Neurooncol 2015;123:65–73 doi:10.1007/s11060-015-1779-0 pmid:25862008

    CrossRefPubMed
22. 22.↵
    2. Patay Z,
    3. DeSain LA,
    4. Hwang SN, et al

    . MR imaging characteristics of wingless-type-subgroup pediatric medulloblastoma. AJNR Am J Neuroradiol 2015;36:2386–93 doi:10.3174/ajnr.A4495 pmid:26338912

    Abstract/FREE Full Text
23. 23.↵
    2. Perreault S,
    3. Ramaswamy V,
    4. Achrol AS, et al

    . MRI surrogates for molecular subgroups of medulloblastoma. AJNR Am J Neuroradiol 2014;35:1263–69 doi:10.3174/ajnr.A3990 pmid:24831600

    Abstract/FREE Full Text
24. 24.↵
    2. Teo WY,
    3. Shen J,
    4. Su JM, et al

    . Implications of tumor location on subtypes of medulloblastoma. Pediatr Blood Cancer 2013;60:1408–10 doi:10.1002/pbc.24511 pmid:23512859

    CrossRefPubMed
25. 25.↵
    2. Yeom KW,
    3. Mobley BC,
    4. Lober RM, et al

    . Distinctive MRI features of pediatric medulloblastoma subtypes. AJR Am J Roentgenol 2013;200:895–903 doi:10.2214/AJR.12.9249 pmid:23521467

    CrossRefPubMed
26. 26.↵
    2. Zhao F,
    3. Li C,
    4. Zhou Q, et al

    . Distinctive localization and MRI features correlate of molecular subgroups in adult medulloblastoma. J Neurooncol 2017;135:353–60 doi:10.1007/s11060-017-2581-y pmid:28808827

    CrossRefPubMed
27. 27.↵
    2. Northcott PA,
    3. Shih DJ,
    4. Remke M, et al

    . Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples. Acta Neuropathol 2012;123:615–26 doi:10.1007/s00401-011-0899-7 pmid:22057785

    CrossRefPubMedWeb of Science
28. 28.↵
    2. Echegaray S,
    3. Bakr S,
    4. Rubin DL, et al

    . Quantitative Image Feature Engine (QIFE): an open-source, modular engine for 3D quantitative feature extraction from volumetric medical images. J Digit Imaging 2018;31:403–14 doi:10.1007/s10278-017-0019-x pmid:28993897

    CrossRefPubMed
29. 29.↵
    2. Wilcoxin F

    . Probability tables for individual comparisons by ranking methods. Biometrics 1947;3:119–22 doi:10.2307/3001946 pmid:18903631

    CrossRefPubMedWeb of Science
30. 30.↵
    2. Pajtler KW,
    3. Witt H,
    4. Sill M, et al

    . Molecular classification of ependymal tumors across all CNS compartments, histopathological grades, and age groups. Cancer Cell 2015;27:728–43 doi:10.1016/j.ccell.2015.04.002 pmid:25965575

    CrossRefPubMed
31. 31.↵
    2. Northcott PA,
    3. Buchhalter I,
    4. Morrissy AS, et al

    . The whole-genome landscape of medulloblastoma subtypes. Nature 2017;547:311–17 doi:10.1038/nature22973 pmid:28726821

    CrossRefPubMed
32. 32.↵
    2. Cavalli FM,
    3. Remke M,
    4. Rampasek L, et al

    . Intertumoral heterogeneity within medulloblastoma subgroups. Cancer Cell 2017;31:737–54.e6 doi:10.1016/j.ccell.2017.05.005 pmid:28609654

    CrossRefPubMed
33. 33.↵
    2. Gatenby RA,
    3. Grove O,
    4. Gillies RJ

    . Quantitative imaging in cancer evolution and ecology. Radiology 2013;269:8–15 doi:10.1148/radiol.13122697 pmid:24062559

    CrossRefPubMed
34. 34.↵
    2. Kickingereder P,
    3. Neuberger U,
    4. Bonekamp D, et al

    . Radiomic subtyping improves disease stratification beyond key molecular, clinical and standard imaging characteristics in patients with glioblastoma. Neuro Oncol 2018;20:848–57 doi:10.1093/neuonc/nox188 pmid:29036412

    CrossRefPubMed
35. 35.↵
    2. Grossmann P,
    3. Narayan V,
    4. Chang K, et al

    . Quantitative imaging biomarkers for risk stratification of patients with recurrent glioblastoma treated with bevacizumab. Neuro Oncol 2017;19:1688–97 doi:10.1093/neuonc/nox092 pmid:28499022

    CrossRefPubMed
36. 36.↵
    2. Hu LS,
    3. Ning S,
    4. Eschbacher JM, et al

    . Radiogenomics to characterize regional genetic heterogeneity in glioblastoma. Neuro Oncol 2017;19:128–37 doi:10.1093/neuonc/now135 pmid:27502248

    CrossRefPubMed
37. 37.↵
    2. Northcott PA,
    3. Shih DJ,
    4. Peacock J, et al

    . Subgroup-specific structural variation across 1,000 medulloblastoma genomes. Nature 2012;488:49–56 doi:10.1038/nature11327 pmid:22832581

    CrossRefPubMedWeb of Science
38. 38.↵
    2. Lastowska M,
    3. Trubicka J,
    4. Niemira M, et al

    . Medulloblastoma with transitional features between group 3 and group 4 is associated with good prognosis. J Neurooncol 2018;138:231–40 doi:10.1007/s11060-018-2797-5 pmid:29427151

    CrossRefPubMed
39. 39.↵
    2. Ellison DW,
    3. Dalton J,
    4. Kocak M, et al

    . Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups. Acta Neuropathol 2011;121:381–96 doi:10.1007/s00401-011-0800-8 pmid:21267586

    CrossRefPubMedWeb of Science
40. 40.↵
    2. Ford J,
    3. Dogan N,
    4. Young L, et al

    . Quantitative radiomics: impact of pulse sequence parameter selection on MRI-based textural features of the brain. Contrast Media & Molecular Imaging 2018. https://doi.org/10.1155/2018/1729071. Accessed August 16, 2018